AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
2
Is your solitaire opponent actually a bot?
3
Cloudera acquires Israeli startup Octopai to advance metadata and AI integration
4
Former Snyk founder Guy Podjarny secures $125M for AI-powered software startup Tessl
5
CyberArk and Wiz join forces to enhance cloud security in multi-cloud environments
More news

IPO

17 stories about IPO
רכבת ישראל תחנת חדרה

Train Safety Company Rail Vision Considers Nasdaq IPO

09.11.17|Golan Hazani
The company announced it is examining registration on Nasdaq, confirming an earlier Calcalist report
כנס מכון אהרון שלמה דברת

Venture Capitalist Sees a Window of Opportunity for Tech IPO Hopefuls

02.11.17|Meir Orbach
Israeli tech is emerging from an extended IPO and M&A slowdown says Viola Ventures founding partner Shlomo Dovrat
קטרינה לייק סטיטצ' פיקס

How Much is Stitch Fix Worth?

02.11.17|Assaf Gilad
A case study valuating pre-IPO companies
רון יקותיאל מייסד מנכל קולטורה הוועידה המוטסת סן פרנסיסקו

Video Company Kaltura on Path for U.S. IPO

01.11.17|Golan Hazani
Kaltura raised $50 million in 2016 from Goldman Sachs at an undisclosed valuation. In May a veteran chief financial officer who led past U.S. IPO joined the company
מנכ"ל פורסקאוט מייקל דסיזאר

Private Investment Terms Dampen Forescout’s Successful IPO

29.10.17|Lilach Baumer
On Friday, Forescout raised $116 million on its Nasdaq debut, selling 5.3 million shares at $22 per share
קטרינה לייק סטיטצ' פיקס

Five Interesting Points from Stitch Fix IPO Prospectus

23.10.17|Daniel Shinar
Daniel Shinar finds hidden gems in the prospectus of the online fashion retailer
מנכ"ל פורסקאוט מייקל דסיזאר

ForeScout Updates Prospectus, Targets a $942 Million Valuation for IPO

19.10.17|Dror Reich
The information security company aims to raise $96-$105.6 million in a Nasdaq IPO
אמיר וייסברג

Drug Conduction Company Prepares for Nasdaq IPO

08.10.17|Golan Hazani
Clinical stage PolyPid develops technology for the predetermined, controlled and localized release of drugs at a targeted site
מנכ"ל פורסקאוט מייקל דסיזאר

Forescout Files For $100 Million Nasdaq IPO

04.10.17|Dror Reich
Underwriters for the intended initial public offering are Morgan Stanley and J.P. Morgan
סנאפצ'ט snapchat

Snap Partners With Advertising Company to Boost Revenue

03.10.17|Dror Reich and Amarelle Wenkert
The social platform partners with ad-tech company Perion’s creative ad division in attempt to boost ad revenue
בורסת הונג קונג בורסה בורסות אסיה

Sisram Stock Price Down on Market Debut

19.09.17|Amarelle Wenkert
The Fosun Pharma subsidiary debuted on the Hong Kong Stock Exchange Tuesday
default image

IPO Hopeful Entera Bio Moves to Better Position

13.09.17|Dror Reich
Clinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism
רכבת ישראל

Train Safety Company Rail Vision Plans Nasdaq IPO

04.09.17|Golan Hazani
The company hopes to raise $25 million with a $100 million company valuation
default image

Acne Cream Developer Sol-Gel files for $86 Million Nasdaq IPO

31.08.17|Dror Reich
The clinical-stage drug developer will remain a "controlled company" under current shareholder Arkin Dermatology
default image

Anti-Acne Drug Developer Plans Nasdaq IPO

15.08.17|Golan Hazani
Sol-Gel approached potential underwriters. It aims to go public before the end of the year
גואו גואנצ'אנג יו"ר קבוצת פוסון

Fosun Filed to Float Alma Lasers in Hong Kong

27.07.17|Golan Hazani and Meir Orbach
Fosun Pharma filed to list the medical equipment company it bought in 2013 on the Hong Kong Stock Exchange
מגדל שרונה ב תל אביב

Israeli Tech Exits Plummet in 2017, Report Says

06.07.17|Meir Orbach
Israeli-related technology companies were sold for $1.5 billion in the first half of 2017 – less than a third of the lowest annual total in the past five years, a new report says
Previous Articles